Actively Recruiting

Age: 18Years +
All Genders
NCT04454177

SMART Watch Facilitated Early Discharge in Patients Undergoing Transcatheter Aortic Valve Replacement

Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2020-10-27

100

Participants Needed

1

Research Sites

571 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to observe conduction disturbance, daily activity level, heart rates, oxygen saturation in patients who underwent Transcatheter Aortic Valve Replacement (TAVR) and to evaluate the utility of the HUAWEI Watch (HUAWEI Technologies Co., Ltd., Shenzhen, China) for the potential early warning sign of changes in multiple biometric parameters including heart rate, rhythm, oxygen saturation, activity, and sleep in patients following TAVR. This will be evaluated in the context of a recently implemented early discharge protocol.

CONDITIONS

Official Title

SMART Watch Facilitated Early Discharge in Patients Undergoing Transcatheter Aortic Valve Replacement

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • At least 18 years old
  • Willing and able to provide informed consent
  • Do not share HUAWEI Watch or phone with others
  • Severe aortic stenosis with echocardiographic criteria: mean gradient > 40mmHg, maximum velocity > 4.0 m/s, or aortic valve area < 1.0 cm2
  • Undergoing elective transfemoral transcatheter aortic valve replacement
Not Eligible

You will not qualify if you...

  • Severe complications from TAVR such as death or conversion to surgical aortic valve replacement
  • Life expectancy under 12 months due to non-heart diseases (e.g., cancer, chronic liver, kidney, or end-stage lung disease)
  • Severe dementia preventing informed consent or self-care
  • Investigator judges patient unsuitable for study or follow-up due to medical, social, or psychological reasons
  • Currently participating in another randomized study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Second Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, China, 310000

Actively Recruiting

Loading map...

Research Team

J

Jiaqi Fan, MD

CONTACT

X

Xianbao Liu, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here